Pathology and Cell Biology
USF Health - College of Medicine
Login here to update your profile  
My Profile

Svitlana Garbuzova-Davis , PHD

Primary Department: CENTER OF EXCELLENCE FOR AGING & BRAIN REPAIR

Assistant Professor
COLLEGE OF MEDICINE MOLECULAR PHARMACOLOGY & PHYSIOLOGY

Assistant Professor
COLLEGE OF MEDICINE PATHOLOGY & CELL BIOLOGY

Assoc Professor
CENTER OF EXCELLENCE FOR AGING & BRAIN REPAIR
profile Image
Contacts
Email: sgarbuzo@health.usf.edu
Phone: (813) 974-3189
Office: ,
 
Education
  • PHD, Biological Sciences, Kharkov State University , Ukraine - 1987.
    		•
     
     


    Selected Publications
  • Garbuzova-Davis, S.Saporta, S.Sanberg, PR. Implications of blood-brain barrier disruption in ALS. Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 9(6): 375-6, 2008.
  • Garbuzova-Davis, S.Sanberg, CD.Kuzmin-Nichols, N.Willing, AE.Gemma, C.Bickford, PC.Miller, C.Rossi, R.Sanberg, PR. Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose. PloS one. 3(6): e2494, 2008.
  • Ajmo, CT.Vernon, DO.Collier, L.Hall, AA.Garbuzova-Davis, S.Willing, A.Pennypacker, KR. The spleen contributes to stroke-induced neurodegeneration. Journal of neuroscience research. 86(10): 2227-34, 2008.
  • Willing, AE.Garbuzova-Davis, S.Sanberg, PR.Saporta, S. Routes of stem cell administration in the adult rodent. Methods in molecular biology (Clifton, N.J.). 438(): 383-401, 2008.
  • Sanberg, PR.Willing, AE.Garbuzova-Davis, S.Bickford, PC.Van Loveren, H.Klasko, SK.Sanberg, CD.Borlongan, CV.Eve, DJ. Navigating cellular repair for the central nervous system. Clinical neurosurgery. 55(): 133-7, 2008.
  • Garbuzova-Davis, S.Klasko, SK.Sanberg, PR. Intravenous administration of human umbilical cord blood cells in an animal model of MPS III B. The Journal of comparative neurology. 515(1): 93-101, 2009.
  • Saleh, IA.Zesiewicz, T.Xie, Y.Sullivan, KL.Miller, AM.Kuzmin-Nichols, N.Sanberg, PR.Garbuzova-Davis, S. Evaluation of humoral immune response in adaptive immunity in ALS patients during disease progression. Journal of neuroimmunology. 215(1-2): 96-101, 2009.
  • Gografe, SI.Sanberg, PR.Chamizo, W.Monforte, H.Garbuzova-Davis, S. Novel pathologic findings associated with urinary retention in a mouse model of mucopolysaccharidosis type IIIB. Comparative medicine. 59(2): 139-46, 2009.
  • Garbuzova-Davis, S.Sanberg, PR. Feasibility of cell therapy for amyotrophic lateral sclerosis. Experimental neurology. 216(1): 3-6, 2009.
  • Sanberg, PR.Eve, DJ.Willing, AE.Garbuzova-Davis, S.Tan, J.Sanberg, CD.Allickson, JG.Cruz, LE.Borlongan, CV. The treatment of neurodegenerative disorders using umbilical cord blood and menstrual blood-derived stem cells. Cell transplantation. (): , 2010.
  • Chen, N.Newcomb, J.Garbuzova-Davis, S.Davis Sanberg, C.Sanberg, PR.Willing, AE. Human Umbilical Cord Blood Cells Have Trophic Effects on Young and Aging Hippocampal Neurons in Vitro. Aging and disease. 1(3): 173-190, 2010.
  • Garbuzova-Davis, S.Woods, RL.Louis, MK.Zesiewicz, TA.Kuzmin-Nichols, N.Sullivan, KL.Miller, AM.Hernandez-Ontiveros, DG.Sanberg, PR. Reduction of circulating endothelial cells in peripheral blood of ALS patients. PloS one. 5(5): e10614, 2010.

    • Grants
  • CORD BLOOD CELLS TO TREAT SAN FILIPPO ($50,000.00, 09/01/2009-12/31/2010)
  • BLOOD-BRAIN BARRIER EVALUATION IN ALS PATIENTS ($104,500.00, 07/01/2008-12/31/2010)
  • BLOOD-BRAIN BARRIER EVALUATION IN ALS PATIENTS ($110,000.00, 07/01/2008-06/30/2010)
  • CORD BLOOD MONOCYTE/MACROPHAGE CELLS TO TREAT SANFILIPPO ($50,000.00, 01/01/2008-12/31/2008)
  • HUMAN UMBILICAL CORD BLOOD TREATMENT IN AN ANIMAL MODEL OF METABOLIC DISORDER ($12,000.00, 07/01/2007-12/01/2008)
  • CORD BLOOD VOLUME-REDUCED NUCLEATED CELLS TO TREAT SANFILIPPO ($35,000.00, 06/01/2006-10/01/2007)
  • CORD BLOOD VOLUME-REDUCED NUCLEATED CELLS TO TREAT SAN FILIPPO ($25,000.00, 10/01/2004-09/30/2005)
  • CORD BLOOD CELLS IN ALS: REPLACEMENT OR PROTECTION ($46,216.00, 08/01/2004-07/31/2005)
  • UMBILICAL CORD BLOOD-DERIVED STEM CELLS TO TREAT ALS ($17,500.00, 07/01/2002-12/31/2003)


    • Lectures
  • "Human umbilical cord blood in treatment of Sanfilippo syndrome type B" American Society for Neural Transplantation, 16th Annual Meeting. FL, United States - 2009.

    • Profile last modified on 02/08/2011